Literature DB >> 28317380

Systems Biology Reveals NS4B-Cyclophilin A Interaction: A New Target to Inhibit YFV Replication.

Alessandra Vidotto1, Ana T S Morais1, Milene R Ribeiro1, Carolina C Pacca1, Ana C B Terzian1, Laura H V G Gil2, Ronaldo Mohana-Borges3, Philippe Gallay4, Mauricio L Nogueira1.   

Abstract

Yellow fever virus (YFV) replication is highly dependent on host cell factors. YFV NS4B is reported to be involved in viral replication and immune evasion. Here interactions between NS4B and human proteins were determined using a GST pull-down assay and analyzed using 1-DE and LC-MS/MS. We present a total of 207 proteins confirmed using Scaffold 3 Software. Cyclophilin A (CypA), a protein that has been shown to be necessary for the positive regulation of flavivirus replication, was identified as a possible NS4B partner. 59 proteins were found to be significantly increased when compared with a negative control, and CypA exhibited the greatest difference, with a 22-fold change. Fisher's exact test was significant for 58 proteins, and the p value of CypA was the most significant (0.000000019). The Ingenuity Systems software identified 16 pathways, and this analysis indicated sirolimus, an mTOR pathway inhibitor, as a potential inhibitor of CypA. Immunofluorescence and viral plaque assays showed a significant reduction in YFV replication using sirolimus and cyclosporine A (CsA) as inhibitors. Furthermore, YFV replication was strongly inhibited in cells treated with both inhibitors using reporter BHK-21-rep-YFV17D-LucNeoIres cells. Taken together, these data suggest that CypA-NS4B interaction regulates YFV replication. Finally, we present the first evidence that YFV inhibition may depend on NS4B-CypA interaction.

Entities:  

Keywords:  NS4B; cyclophilin A; cyclosporine A; protein interactions; proteomics; sirolimus; systems biology; yellow fever virus

Mesh:

Substances:

Year:  2017        PMID: 28317380     DOI: 10.1021/acs.jproteome.6b00933

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Application of multiple omics and network projection analyses to drug repositioning for pathogenic mosquito-borne viruses.

Authors:  Takayuki Amemiya; Katsuhisa Horimoto; Kazuhiko Fukui
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

2.  Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses.

Authors:  Takayuki Amemiya; M Michael Gromiha; Katsuhisa Horimoto; Kazuhiko Fukui
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 3.  Cyclophilin A: a key player for etiological agent infection.

Authors:  Yating Liao; Dan Luo; Kailan Peng; Yanhua Zeng
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-25       Impact factor: 5.560

Review 4.  Dengue virus NS4B protein as a target for developing antivirals.

Authors:  Qingxin Li; Congbao Kang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-09       Impact factor: 6.073

5.  Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.

Authors:  Quentin Nevers; Isaac Ruiz; Jean-Michel Pawlotsky; Abdelhakim Ahmed-Belkacem; Nazim Ahnou; Flora Donati; Rozenn Brillet; Laurent Softic; Maxime Chazal; Nolwenn Jouvenet; Slim Fourati; Camille Baudesson; Patrice Bruscella; Muriel Gelin; Jean-François Guichou
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 6.  Cyclophilins and cyclophilin inhibitors in nidovirus replication.

Authors:  Adriaan H de Wilde; Uyen Pham; Clara C Posthuma; Eric J Snijder
Journal:  Virology       Date:  2018-07-12       Impact factor: 3.616

7.  TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation.

Authors:  Abhilash I Chiramel; Nicholas R Meyerson; Kristin L McNally; Rebecca M Broeckel; Vanessa R Montoya; Omayra Méndez-Solís; Shelly J Robertson; Gail L Sturdevant; Kirk J Lubick; Vinod Nair; Brian H Youseff; Robin M Ireland; Catharine M Bosio; Kyusik Kim; Jeremy Luban; Vanessa M Hirsch; R Travis Taylor; Fadila Bouamr; Sara L Sawyer; Sonja M Best
Journal:  Cell Rep       Date:  2019-06-11       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.